Andy Bredemeyer, Ph.D.
Dr. Bredemeyer brings to PierianDx extensive experience in laboratory operations. Since earning his doctorate in Immunology at Washington University in St. Louis, he has directed his analytical acumen towards developing and improving business processes in laboratory environments. Dr. Bredemeyer has served in policy and finance roles at the NIH and at Massachusetts General Hospital research labs. Most recently, he led the development and validation of next generation sequencing based clinical assays at Washington University’s Genomics and Pathology Services laboratory.